A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
Clinical trial NCT00102219 · COMPLETED
Trial details
- NCT number
- NCT00102219
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.